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Purpose: To evaluate the expression patterns of cytokeratin (K) 12, 13, and 19 in normal epithelium of the human ocular
surface to determine whether K13 could be used as a marker for conjunctival epithelium.
Methods: Total RNA was isolated from the human conjunctiva and central cornea. Those transcripts that had threefolds
or higher expression levels in the conjunctiva than the cornea were identified using microarray technique. Expression
levels of three known signature genes and of two conjunctival genes, K13 and K19 were confirmed by using quantitative
real-time PCR (qRT–PCR). Protein expression of K12, K13, and K19 was confirmed by immunostaining with specific
antibodies on histologic sections of human sclerocornea that contained the conjunctiva, limbus, and cornea and on
impression cytology (IC) specimens of the cornea and conjunctiva from normal donors. Double staining of K13/K12 and
K19/K12 on histologic sections and IC specimens was performed.
Results: There were 337 transcripts that were preferentially expressed in the conjunctiva. K13 and K19 were among the
top twenty transcripts in the conjunctiva and this preferential expression pattern of K13 and K19 was confirmed by qRT–
PCR. Immunohistochemical studies showed that K13 was expressed at the posterior limbal epithelium and conjunctival
epithelium but was totally absent in the cornea. K12 was expressed in the corneal and anterior limbal epithelia except for
the basal layer and was absent from the conjunctiva. In contrast, K19 was detected in the corneal, limbal and conjunctival
epithelia. Immunostaining of the IC specimens showed K12+ epithelial cells in the corneal region, K13+ cells in the
conjunctival area, and K19+ cells in the corneal and conjunctival specimens. Expression of K13 and K12 on the ocular
surface was mutually exclusive on both the histologic and IC samples using double immunostaining.
Conclusions: K13 is more specific to the conjunctival epithelial cells than K19 and potentially could be used as a marker
to identify conjunctival epithelial cells in limbal stem cell deficiency.
The ocular surface is lined by the corneal and
conjunctival epithelia. Despite having different phenotypes
and histogeneses, both epithelia form a continuous layer and
function as barriers to protect the ocular surface from injury,
infection, and desiccation. The human corneal epithelial stem
cells (limbal stem cells [LSCs]) are presumed to locate in the
limbus, ie, the transitional zone between the cornea and the
conjunctiva, and they maintain the homeostasis of corneal
epithelial cells [1,2]. When LSCs are damaged or deficient,
the conjunctival epithelium invades the corneal surface, and
this invasion leads to corneal opacity and neovascularization
[3]. This conjunctivalization process on the corneal surface
severely impairs vision and causes blindness at the end stage
[4].
Correspondence to: Sophie X. Deng, M.D., Ph.D., Assistant
Professor of Ophthalmology, Cornea and Uveitis Division, Jules
Stein Eye Institute-UCLA, 100 Stein Plaza, Los Angeles, CA, 90095;
Phone: (310) 206-7202; FAX: (310) 794-7906; email:
deng@jsei.ucla.edu
Diagnosis of LSC deficiency (LSCD) is made by clinical
examination and confirmed by impression cytology (IC) [5].
The presence of goblet cells on the cornea indicates the
presence of conjunctival epithelium. However, in many ocular
disorders in which LSCD is observed, goblet cell deficiency
also coexists, and this coexistence leads to a false-negative
result. Egbert et al. [6] found that it is difficult to distinguish
conjunctival epithelia from corneal epithelia by conventional
cytology techniques.
The identification of a marker that is expressed in the
conjunctival epithelium but not in the corneal epithelium has
been a growing need. Good candidates are cytokeratins, which
comprise a family of intermediate filament cytoskeletal
proteins in epithelial cells and are divided into the type I
(acidic) and type II (basic to neutral) subfamilies.
Cytokeratins form filaments responsible for the integrity of
the epithelial cell structure, and because of their different
patterns of expression, these proteins could be used as
differentiation markers [7]. The corneal epithelium, but not
the conjunctival epithelium, expresses cytokeratin (K) 12 [8].
Although K19 was proposed initially by Donisi et al. [9] as a
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specific marker of conjunctival epithelial cells and used by
others to diagnose LSCD, other groups found that K19 is not
specific to conjunctival epithelial cells because it is expressed
in corneal epithelial cells as well [10-12]. Barbaro et al. [13]
recently compared K12 and K19 expression in both
sclerocorneal tissues and IC specimens and their results
confirmed the previous finding that K19 is not specific to
conjunctival epithelial cells. A more specific marker of limbal
and conjunctival epithelia would be necessary to detect non-
corneal epithelial cells on the corneal surface.
To search for conjunctival specific marker(s), we first
performed preferential gene profiling in the conjunctiva in
direct comparison to that in the cornea using microarray
technique. K13 and K19 transcripts were among the genes
preferentially expressed in the human conjunctiva and their
expression levels were confirmed using qRT–PCR. The
detailed expression patterns of K13, K19, and K12 on the
human ocular surface were then compared by
immunohistochemistry and confirmed on impression
cytology specimens. K13 was expressed only in the posterior
limbal and conjunctival epithelia and completely absent on
the cornea.
METHODS
Human sclerocorneal tissue: Human sclerocorneal tissue of
nine healthy donors (age range, 2 to 62 years) was obtained
from the Lions Eye Institute for Transplant and Research
(Tampa, FL), the Tissue Bank International (Baltimore, MD),
and the San Diego Eye Bank (San Diego, CA). The
experimental protocol was evaluated and approved by the
Institutional Review Boards of the University of California,
Los Angeles. Six donor tissues were used in the
immunohistochemical study. The death to preservation time
was less than 8 h, and the time to tissue processing was less
than 4 days. For RNA isolation, the death to preservation time
was less than 6 h and the tissues were either snap frozen on
dry ice or stored in RNAlater (Ambion Inc., Austin, TX).
Three donors were used in the microarray experiment.
RNA isolation and microarray analysis: The conjunctival and
corneal epithelia along with their immediate adjacent stroma
were dissected from human sclerocorneal tissues. RNA was
isolated as described previously [14]. Briefly, tissues were
homogenized in RLT lysis buffer (Qiagen, Valencia, CA) and
total RNA from tissues was extracted with the Qiagen RNeasy
Mini Kit (Qiagen). The quantity and quality of total RNA were
assessed by a NanoDrop 1000 spectrophotometer (NanoDrop,
Wilmington, DE) and a 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA). Only those samples that had
an RNA integrity number >9 and exhibited minimal RNA
degradation were used for subsequent experiments.
Microarray analysis was performed as previously described
[14]. Briefly, one transcription amplification was performed.
Synthesis for all samples was successful and provided a
sufficient yield of cRNA. Affymetrix U133 plus 2.0 human
expression arrays (Affymetrix, Santa Clara, CA) was used in
accordance with the standard Affymetrix protocol for
eukaryotic expression arrays. All microarrays were scanned
by using an Affymetrix 3000 one-color microarray scanner.
Raw images were examined for surface defects and for proper
grid placement. Background intensity, housekeeping gene
expression, and a 3′-to-5′ ratio of probe sets for genes of
varying lengths were also used to assess the quality. Probe
intensity values were generated by using the Affymetrix Gene
Chip Operating System. The gene whose expression in the
conjunctiva was at least threefold higher than that in the
cornea and whose level was ≥145 (1% of the highest
expression level in the conjunctiva) was considered to be
differentially expressed. We have deposited the raw data at
Gene Expression Omnibus (GEO) under accession number
GSE29402 and we can confirm all details are Minimum
Information About a Microarray Experiment (MIAME)
compliant.
Quantitative RT–PCR: Total RNA was reverse-transcribed by
using Superscript II RNase H2 reverse transcriptase (RT;
Invitrogen, Carlsbad, CA) according to the manufacturer's
recommendations. The relative abundance of transcripts was
detected through qRT–PCR by using a Brilliant SYBR Green
qRT–PCR Master Mix (Stratagene, La Jolla, CA). The
protocol used an Eppendorf realplex2 real-time PCR system
(Hamburg, Germany). The primers used for qRT–PCR are
listed in Table 1. Cycling conditions were as follows: an initial
denaturing step of 10 min at 95 °C and subsequent 40 cycles
of amplification in which each cycle consisted of 45 s at 95 °C,
30 s at 55 °C, and 15 s at 72 °C. To generate a dissociation
curve after the amplification cycles, each sample was
incubated at 95 °C for 15 s and then subjected to a melting
curve program (60–95 °C). The fluorescence intensity of each
sample was acquired during the execution of the melting curve
program and normalized in relation to that of the
housekeeping gene, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The average value of triplicates
from each transcript was used for comparison.
Immunohistochemistry: Human sclerocorneal tissues were cut
into four quadrants and embedded in Optimal Cutting
Temperature Compound (OCT; Tissue-Tek, Torrance, CA)
on dry ice. Tissues were cut into 6–8 μm sections with a
cryostat and stored at −80 °C. The primary and secondary
antibodies used are listed in Table 2. Frozen section slides
were warmed in a desiccator at room temperature, fixed with
4% paraformaldehyde for 15 min, washed with phosphate-
buffered saline (PBS) three times, and blocked with 5%
normal donkey serum (Jackson ImmunoResearch
Laboratories, West Grove, PA) in PBS for 30 min. The slides
were washed with 1% BSA (BSA)/PBS three times and
incubated with the primary antibodies for 60 min at room
temperature. The slides were washed with 1% BSA/PBS three
times and subsequently incubated with the appropriate
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secondary antibody. Afterward, the slides were washed with
1% BSA/PBS three times, and the nuclei were labeled with
Hoechst 33342 (0.5 μg/ml) for 15 min. The slides were
washed with PBS five times and mounted. For double
staining, the slides were incubated with the primary antibody
for 1 h at room temperature, washed with 1% BSA/PBS three
times, and incubated with the appropriate secondary antibody.
The slides were then incubated with the second primary
antibody for 1 h at room temperature, washed with 1% BSA/
PBS three times, incubated with the appropriate secondary
antibody for 1 h at room temperature, and washed with 1%
BSA/PBS three times. Nuclei were labeled with Hoechst
33342 as above. The slides were washed with PBS five times
and mounted. Pictures were taken under a 25× objective lens
by using a Zeiss fluorescent microscope (Oberkochen,
Germany).
Impression Cytology: A sterile, round, single-packed Biopore
0.45-µm membrane (Millipore Corp., Bedford, MA) was
placed on the cornea of the sclerocorneal tissues. Gentle
pressure was applied for a few seconds. The membrane was
then peeled off. To obtain conjunctival epithelial cells, the
membrane was applied to the conjunctiva only in the same
manner. The membranes that contained epithelial cells were
then fixed with 4% paraformaldehyde for 15 min, washed with
PBS three times, and blocked with 5% normal donkey serum
(Jackson ImmunoResearch Laboratories) in PBS for 30 min.
The membranes were immunostained with anti-K12, anti-
K13, and anti-K19 antibodies as described above.
Data analysis: All Affymetrix data were normalized by using
the justRMA algorithm of R software from the Bioconductor
group [15], which implements the RMA (robust multiarray
average) normalization method [16]. In this normalization
step, each array was individually normalized by combining it
with a pool of 50 fixed reference arrays in the Microarray Core
Facility at the University of California, Los Angeles. Genes
whose expression values were at least threefold greater than
those in the other tissue type were selected and considered to
be differentially expressed. DAVID (the database for
annotation, visualization and integrated discovery) was used
for functional analysis [17]. Lists of differentially expressed
genes were checked by DAVID to find the most over-
represented gene groups. The data was obtained from 3
different donors.
Statistical analysis: To eliminate the variation between
experiments in the qRT–PCR, the absolute expression value
(highest for either the conjunctiva or cornea) was set at 1 and
the ratios of absolute values were calculated between tissues
and averaged. A Wilcoxon Signed-rank test was performed
on the ratio values and a Student’s t test on the quantitation of
cell populations. A p value <0.05 was considered statistically
significant.
TABLE 1. QRT–PCR PRIMERS.
Gene Direction Primer sequence
K12 Forward CCAGGTGAGGTCAGCGTAGAA
 Reverse CCTCCAGGTTGCTGATGAGC
K13 Forward CTGAACAAGGAGGTGTCTACCA
 Reverse ATAGCGGCACTCCGTCTCT
K15 Forward ACCACCACATTTCTGCAAACT
 Reverse AGCTGAGATACTTCGGCTTCC
K19 Forward TGAGTGACATGCGAAGCCAAT
 Reverse ACCTCCCGGTTCAATTCTTCA
Mucin 5AC Forward CAGCCACGTCCCCTTCAATA
 Reverse ACCGCATTTGGGCATCC
GAPDH Forward GGCTGAGAACGGGAAGCTTGTCAT
 Reverse CAGCCTTCTCCATGGTGGTGAAGA
???????????????Abbreviations: Cytokeratin, K; Glyceraldehyde 3-phosphate dehydrogenase, GAPDH.
TABLE 2. PRIMARY AND SECONDARY ANTIBODIES.
Protein Company Host Species
reactivity
Clone/ catalog #
Cytokeratin 12 Santa Cruz Biotechnology, Santa Cruz, CA goat human sc-17101
Cytokeratin 13 Santa Cruz Biotechnology, Santa Cruz, CA mouse Human c-101460
Cytokeratin 19 Dako North America Inc., Carpinteria, CA mouse human RCK108
Cytokeratin 19 Leica Microsystems INC, Bannockburn, Il mouse human b170
Alexa Fluor 488 IgG Invitrogen, Carlsbad, CA donkey goat A11055
Alexa Fluor 546 IgG Invitrogen, Carlsbad, CA donkey mouse A10036
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RESULTS
The RNA quality assessed by using the nano chip revealed a
flat baseline with no significant tailing of the rRNA bands
(data not shown) and the S18-to-S23 ratios were between 1.6
and 2.1. The RNA isolated from all tissues appeared to have
little degradation.
There were 337 transcripts predominantly overexpressed
in the conjunctiva. Of the 337 preferentially expressed
transcripts in the conjunctiva, 331 encoded proteins with
known functions. The top 20 transcripts that were
preferentially overexpressed in the conjunctiva are listed in
Table 3. Interestingly, both K19 and K13 were among the
preferential intermediate filaments in the conjunctiva.
To validate our microarray data, we analyzed the
expression pattern of several well known signature genes in
the cornea and conjunctiva from the global mean intensity
values. One of the cornea epithelium markers, keratin 12 [2]
was highly expressed in the cornea. Keratin 15, which had
been shown to be exclusively expressed at the basal epithelial
layer of the limbus and conjunctiva [10], had a higher
transcription level in the conjunctiva than cornea (Figure 1A).
Mucin 5AC, a conjunctiva marker [18], was also
preferentially expressed in the conjunctiva but not in the
cornea (Figure 1A). The expression levels of all of these
signature genes of each tissue type were highly correlated with
their expected expression patterns. In addition to the expected
marker expression, both K13 and K19 expression were also
significantly upregulated in the conjunctiva in comparison to
the cornea.
To further verify the microarray method, the five
transcripts with differential expression patterns seen in our
microarray analysis were independently quantified by qRT–
PCR. The expression levels of all five transcripts measured
by qRT-PCR correlated well with those obtained using the
Figure 1. Expression levels of signature
genes and of K13 and K19 in the cornea
and conjunctiva. Expression levels were
obtained by microarray method (A) and
detected by qRT–PCR (B). K12
expression was restricted to the cornea
as expected, whereas K15 and Mucin
5AC, both conjunctival markers, were
expressed almost exclusively in the
conjunctiva. Both K13 and K19
transcripts were also preferentially
expressed in the conjunctiva.
Abbreviations: K, cytokeratin.
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microarray technique (Figure 1B). K13 and K19 were
included in this analysis to confirm their expression
specificity. The levels of K13 and K19 transcripts were
significantly higher in the conjunctiva than in the cornea (both
p<0.05). K13 and K19 mRNA levels were barely detected in
the cornea (Figure 1B). This observation suggested that K13
could be a candidate conjunctival epithelial marker.
Immunohistochemistry was then used to examine the
presence of K13 and K19 in normal human ocular tissues. A
montage of images consisting of the conjunctiva, limbus,
peripheral cornea and central cornea was constructed to show
the detailed expression pattern. As shown in Figure 2A, K13
protein was expressed in the suprabasal limbal epithelium and
in all layers of the conjunctival epithelium but was absent in
all layers of the corneal epithelium, including the central and
peripheral areas. As expected, K12 protein expression was
detected in all layers of the corneal epithelium and the
suprabasal layers of the limbus, but was not observed in the
conjunctival epithelium (Figure 2A). K19 was observed in all
layers of the epithelium in the limbus, and the expression
extended to the mid-peripheral cornea, although the intensity
of the fluorescence toward the center of the cornea decreased
Figure 2. Immunohistochemical analysis of expression patterns of K12, K13, and K19 in normal human histologic sections. Montage images
of serial sections of the central cornea to the conjunctiva (A-C): Double staining of K12 (green) and K13 (red) showed the presence of K13
in the epithelia of the posterior limbus and conjunctiva (A). K19 expression was detected in the peripheral cornea, limbus, and conjunctiva
(B). Double staining of K12 (green) and K19 (red) showed the overlapping expression of both cytokeratins (C). D: Expression of K12 (arrows)
and K13 (arrowheads) were mutually exclusive. E: Details of the overlapping expression of K12 and K19. Arrowhead: cells that expressed
both K12 and K19. Arrow: K12-expressing cell. Abbreviations: Conj., conjunctiva. Magnification bar in A, B, C represents 200 μm.
Magnification bar in D and E represents 50 μm.
Molecular Vision 2011; 17:1652-1661 <http://www.molvis.org/molvis/v17/a183> © 2011 Molecular Vision
1657
(Figure 2B). Only occasionally, the central corneal epithelial
cells expressed K19.
To further evaluate the specificity of the expression of
K13 and K19, double immunostaining of the sclerocorneal
tissue sections was performed. There was a rather abrupt
transition between the K12-expressing and K13-expressing
epithelial cells in the limbus (Figure 2 A,D). The limbal
epithelial cells expressed either K12 or K13. Few cells
expressed both K12 and K13; this finding suggested that
expression of K12 and K13 is mutually exclusive. In contrast,
epithelial cells that expressed both K12 and K19 were located
throughout the limbus and the peripheral cornea (Figure
2B,C,E). Quantitation of each population was performed in
the central and the peripheral cornea (Figure 3). In the central
cornea, nearly all epithelial cells were K12+ and 22.6% of
them also weakly expressed K19 (Figure 3B). In the
peripheral cornea, 97.8% of cells were K12+ and 62.7% of
them also were K19+ (Figure 3B). On average, 97.8% of
epithelial cells expressed K12 and 42.9% of them also
expressed K19 in the cornea (Figure 3B). In contrast, none of
the K12+ cells expressed K13 in the central cornea and there
was no K13 expression in the peripheral cornea (Figure 3A).
The statistical differences between the K12+ cells compared
to either the K13+ or K19+ cells were significant for both the
peripheral and central cornea.
The specificity of K12, K13, and K19 expression was
confirmed on IC specimens of healthy donors. K12 was
detected only in IC specimens from the cornea (Figure 4A),
but not in the conjunctiva (Figure 4B). K13 was present in IC
specimens from the conjunctiva (Figure 4D) but was
completely absent in corneal IC specimens (Figure 4C). In
contrast, K19 was seen in the conjunctival and corneal IC
specimens (Figure 4E,F). Double staining confirmed the
K12+/K19+ cells in the cornea (Figure 4H).
DISCUSSION
The identification of K13 and K19 in conjunctiva from the
microarray analysis and subsequent confirmation through
qRT–PCR and immunostaining strongly validates the
comparative gene expression analysis from the microarray
data. A similar gene expression profile study by Turner et al.
[19] using human genome U133A microarrays, containing
22,283 probe sets, compared RNA samples isolated from
conjunctival and cornea epithelial sheets. Interestingly,
almost all of our preferentially expressed genes in the
conjunctiva, including K13 and K19, were present in their
conjunctiva exclusive or preferential transcript sets, thus
reaffirming the validity of our microarray results despite the
slight difference in the ocular tissues used.
This study compares the expression specificity of K13
and K19 at both the mRNA and protein levels on the human
Figure 3. Specificity of K12, K13, and
K19 expression in human cornea. A:
Percentage of K12+, K13+ and K12+/
K13+ cells in the central (left) and
peripheral cornea (middle). The average
percentages of the three cell populations
are obtained (right). B: Percentage of
K12+, K19+ and K12+/K19+ cells in the
central (left) and peripheral cornea
(middle). The average percentages of
the three cell populations are obtained
(right). The asterisk indicates a p<0.05
between K12+ and K19+ or K13+ cells,
the double asterisk indicates a p<0.05
between K12+ and K12+/19+ or K12+/
K13+ cells.
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Figure 4. Patterns of K 12, 13, and 19 expression in the impression cytology (IC) specimens taken from normal sclerocorneal tissues. A, C,
E, G, and H were from corneal IC specimens. B, D, and F were conjunctival IC specimens. Expression of K12 was present in the corneal
(A) but not in the conjunctival epithelium (B). K13 expression was not detected in corneal epithelium (C) but was highly expressed in the
conjunctival (D) epithelium. K19 was detected in the both corneal (E) and conjunctival (F) epithelia. Double staining of K12/K13 (G) and
K12/K19 (H) in corneal IC specimens. Arrows: K12+/K19+ cells. Magnification bar represents 5 μm.
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ocular surface. Although K19 is expressed at a much lower
level in the central cornea, the finding that K19 was detected
in 62.7% of the corneal epithelial cells in the peripheral cornea
is striking. These observations strongly suggest that K19 is
not specific to the conjunctival epithelium. Using qRT–PCR,
we detected a low level of K19 transcripts in the cornea and
confirmed the accuracy of our immunostaining results. The
qRT–PCR result probably reflects K19 expression in the
peripheral cornea. Our finding is consistent with those
reported previously [10,13,20]. The discrepancy in K19
expression may be due to the immunohistochemistry
technique employed. The length of fixation, the antibody
used, the location of the observation, the quality of specimen,
and the sensitivity of immunofluorescence detection might
affect the outcome of the immunostaining pattern. Over
fixation tends to decrease antibody-antigen binding and hence
reduce detection sensitivity. Only fresh tissues with less than
8 h of death to preservation time were used in our experiments.
We also employed two different anti-K19 antibodies, and both
gave the same immunostaining pattern.
K13, a major acidic keratin, is expressed in the suprabasal
layers of non-cornified stratified epithelia and is mucosa-
specific [21]. In addition, K13 is present in the suprabasal
layers of most stratified squamous epithelia, such as mucosal
epithelia and regenerating epidermis [22,23]. Previous studies
by us and others showed that K13 is expressed in the
conjunctival and limbal epithelia in histological sections
[14,20,24] and in cultured tissue [25], but the detailed
expression pattern on the central and peripheral cornea, and
the limbus has not been studied. This study shows the detailed
expression pattern of K13 and K19 in the central and
peripheral cornea, and the limbus. The finding that K12
expression and K13 expression are mutually exclusive on the
ocular surface makes K13 a potential marker of epithelial cells
that are not of corneal phenotype. This is particularly
important because the clinical signs in the early stage of LSCD
tend to be subtle and not specific. Goblet cells are not always
present and could be missed by the standard IC method. The
detection of non-corneal epithelial cells, particularly in the
peripheral cornea, would be a more sensitive and specific
method of diagnosing early LSCD. Furthermore, the
successful detection of K13 and K12 by immunostaining in
IC specimens would allow for using K13 as a diagnostic
maker of conjunctival epithelium in immunocytology. The
sensitivity of K13 as a marker of non-corneal epithelial cells
will need to be determined on pathologic IC specimens.
In addition to the overexpression of K13 and K19 in the
conjunctiva, two members of the S100 calcium binding
protein family, S100A8 and S100A9, were highly expressed
in the conjunctiva. S100 proteins function as calcium sensors
and upon activation, regulate various cell processes in the
epidermis [26]. It has been shown that S100A8 and S100A9
are normally co-expressed together and in response to wound
healing, these proteins are secreted by human keratinocytes
[27]. Furthermore, localization of both proteins has been
observed in both human conjunctival and pterygial epithelia
[24,28], and S100A8/9 can also bind to keratin intermediate
filaments [29]. Future studies will focus on the specificity of
these partner proteins in the conjunctiva.
Another candidate we examined was the
carcinoembryonic antigen-related cell adhesion molecule 6
(CEACAM6). CEACAM6 belongs to the carcinoembryonic
antigen gene family and has been shown to be localized on
epithelia in intestinal cells [30]. Preliminary immunostaining
showed localization only in the superficial layer of the
conjunctiva and limbus and expression in the cornea was
absent (data not shown). Despite being specific for the
conjunctiva and limbus, the lack of expression in the basal and
suprabasal layers of the epithelia makes this protein an
undesirable marker.
Although not listed in Table 3, the mucin family had
several genes upregulated in the conjunctiva based on the
microarray data, including mucin 5AC and mucin 1. A
previous report proposed that mucin 1 (MUC1) could be used
as a new marker of conjunctival epithelial cells [13]. However,
others have shown that expression of MUC1 is uniform
throughout the entire human ocular surface [18,31]. Further
study is needed to determine the expression specificity of
MUC1 and to resolve this discrepancy before MUC1 could be
accepted as a marker of conjunctival epithelial cells.
In summary, the findings of our study show that K13
expression is specific to non-corneal epithelial cells,
particularly conjunctival epithelial cells on the healthy ocular
surface and K19 is present at substantial levels in the corneal
epithelium. The K13 expression pattern and that of K12 are
mutually exclusive. This unique feature of K13 makes it a
potential candidate as a diagnostic marker to detect the
invasion of conjunctival epithelial cells onto the cornea, a
hallmark of LSCD.
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